Metformin inhibits SUV39H1-mediated migration of prostate cancer cells

Prostate cancer (PCa) is a leading cause of cancer-related death among men, largely due to incurable distant metastases. Metformin, the most common used anti-type-2 diabetes medicine, has been linked to reduced cancer risk and better diagnosis. We found that metformin was able to inhibit PCa cell mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, T, Wang, C, Yang, J, Guo, Y, Wu, Y, Li, X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523061/
https://www.ncbi.nlm.nih.gov/pubmed/28459432
http://dx.doi.org/10.1038/oncsis.2017.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523061/
https://www.ncbi.nlm.nih.gov/pubmed/28459432
http://dx.doi.org/10.1038/oncsis.2017.28

Ejemplares similares